Wockhardt becomes first Indian pharma company to win US FDA approval for self-discovered drug
Wockhardt's new antibiotic marks a turning point for an industry that has typically worked on producing cheaper versions of medicines invented elsewhere
Read the full articleYou might also wanna read
Indiaâs Generic Pharma Industry Is Sitting on a Formulation Data Time Bomb
Discover how fragmented formulation data is slowing India's generic pharma industry and why AI-powered knowledge systems are becoming essent
FDA Drug Regulator Accused of Targeting Former Business Associate's Pharmaceutical Company
FDA regulator accused of using position to exact revenge on old business associate.
arstechnica.com·8mo ago
Croatian researchers thrust into limelight as their 1990sâ peptide discovery goes mainstream in the US
Trump administration hopes to approve peptides popular with MAHA wellbeing advocates. How are the researchers at the centre of this coping w
Spero Therapeutics Aktie: 85-Prozent-Potenzial bis 4 Dollar
Spero Therapeutics hat eigentlich Grund zum Feiern. Mitte Juni gab die US-Gesundheitsbehörde FDA grĂŒnes Licht fĂŒr das neue Medikament Utebzi
Independent US body finds drug shortages are lasting longer as reliability dwindles
The US Pharmacopeiaâs new sweeping report shows shortages are lingering as supply lines falter.
Novo Nordisk: Schritt fĂŒr Schritt
Der dĂ€nische Biopharma-Riese Novo Nordisk bringt seinen AppetitzĂŒgler Wegovy (Semaglutid) in immer mehr LĂ€ndern auf den Markt. Kein Wunder,
Comments
Sign in to join the conversation.
No comments yet. Be the first.